Goldman Sachs downgrades MGY and OXY, reinstates coverage on EXE. MGY's outperformance reflected in current stock price, OXY's leverage a concern. EXE receives Buy rating with potential 18% upside.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback